What is the primary function of Aggrenox?

Aggrenox is primarily used to reduce the risk of stroke and blood clots. This medication is a combination of aspirin and dipyridamole, both of which have specific roles in preventing thrombotic events. Aspirin acts as an antiplatelet agent, inhibiting platelet aggregation, which helps to prevent clots from forming. Dipyridamole enhances the effects of aspirin and has additional mechanisms that further inhibit platelet function.

The use of Aggrenox is indicated particularly for patients who have experienced transient ischemic attacks (TIAs) or have a high risk of developing strokes, making its primary purpose focused on preventing such cardiovascular events. This is distinct from other options, which involve different therapeutic approaches and mechanisms that do not relate to stroke prevention or blood clot management.